Skip to main content
SpringerLink
Log in

Hepatitis C

Should antiviral therapy be offered to elderly patients?

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

Relatively little information exists on the prognosis for elderly patients with chronic hepatitis C (CHC). Moreover, the majority of randomized, clinical trials of hepatitis C treatment exclude elderly patients. Findings from a 2009 clinical study address risk of hepatocellular carcinoma, life expectancy and the influence of antiviral therapy in elderly patients with CHC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Floreani, A. et al. Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? J. Am. Geriatr. Soc. 54, 549–550 (2006).

    Article  Google Scholar 

  2. Ikeda, K., et al. Necessities of interferon therapy in elderly patients with chronic hepatitis C. Am. J. Med. 122, 479–486, (2009).

    Article  CAS  Google Scholar 

  3. Armstrong, G. L. et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144, 705–714 (2006).

    Article  Google Scholar 

  4. Yoshizawa, H., Tanaka, J. & Miyakawa, Y. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology 49, 7–17 (2006).

    Article  Google Scholar 

  5. Heathcote, J. Prevention of hepatitis C-virus related hepatocellular carcinoma. Gastroenterology 127 (Suppl. 1), S294–S302 (2004).

    Article  Google Scholar 

  6. Hot topics in hepatitis C virus treatment: Recommendations from an AISF/SIMID/SIMAST Expert Opinion Meeting [online], (2009).

  7. Thabut, D. et al. Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? Am. J. Gastroenterol. 101, 1260–1267 (2006).

    Article  Google Scholar 

  8. Iwasaki, Y. et al. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. Hepatology 43, 54–63 (2006).

    Article  CAS  Google Scholar 

  9. Marcus, E.-L. & Tur-Kaspa, R. Viral hepatitis in older adults. J. Am. Geriatr. Soc. 45, 755–763 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy

    Annarosa Floreani

Authors
  1. Annarosa Floreani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annarosa Floreani.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Floreani, A. Should antiviral therapy be offered to elderly patients?. Nat Rev Gastroenterol Hepatol 6, 503–504 (2009). https://doi.org/10.1038/nrgastro.2009.138

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2009.138

  • Springer Nature Limited

This article is cited by

Search

Navigation